Both in Pharmaceuticals
Azitra vs Xenetic Biosciences
Over the past year AZTR returned −82.7% and XBIO returned −29.5%; their daily moves had a correlation of 0.06.
AZTR −82.7% XBIO −29.5%Growth of $1, one year, split-adjusted
| Metric | AZTR | XBIO |
|---|---|---|
| Price | $0.8157 | $2.01 |
| Market cap | $4.9M | $4.7M |
| Today | −7.71% | −3.37% |
| 1 month | −37.3% | −5.2% |
| 6 months | −66.7% | −36.6% |
| Year to date | −69.2% | −7.4% |
| 1 year | — | −35.6% |
| Revenue growth (YoY) | — | +12.0% |
| Gross margin | — | 100.0% |
| Net margin | — | −140.7% |
| P/E (TTM) | — | — |
| Price / sales | — | 3.2× |
| Net cash | $6.7M | $6.5M |
| Dividend yield | — | — |
| Volatility (60d) | 222.1% | 158.5% |
| Short % of float | 0.2% | 0.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).